PURPOSE: To benchmark outcomes of a German breast cancer network with the Surveillance Epidemiology and End Results programme (SEER) of the USA from a longitudinal point of view. METHODS: All women receiving primary breast cancer therapy of three hospitals in a rural district of Marburg-Biedenkopf (Germany) of time intervals 1996-1997 and 2003-2004 were used to define local benchmark objects. Data from SEER-programme contributed longitudinal benchmark objects from national level (1988-2004). All benchmark objects were compared with the time-fixed benchmark reference of SEER (2004). Stage distributions and 5-year relative survival ratios were combined to estimate standardized screening-, case-mix-, work-up-, treatment- and relative overall performance index. RESULTS: From the entry cohort of 877 German women, 97.7 % of the patients accounted for the institutional sample (N = 857) and 65.8 % accounted for the regional sample (N = 577). Stage distributions, relative survival ratios and indices of the German breast cancer network improved over time. Developed indices converged with SEER (2004). CONCLUSIONS: Effectiveness gap between one exemplary German breast cancer network and international benchmark defined by SEER has been closed. Reasons are manifold, and further research is recommended.
PURPOSE: To benchmark outcomes of a German breast cancer network with the Surveillance Epidemiology and End Results programme (SEER) of the USA from a longitudinal point of view. METHODS: All women receiving primary breast cancer therapy of three hospitals in a rural district of Marburg-Biedenkopf (Germany) of time intervals 1996-1997 and 2003-2004 were used to define local benchmark objects. Data from SEER-programme contributed longitudinal benchmark objects from national level (1988-2004). All benchmark objects were compared with the time-fixed benchmark reference of SEER (2004). Stage distributions and 5-year relative survival ratios were combined to estimate standardized screening-, case-mix-, work-up-, treatment- and relative overall performance index. RESULTS: From the entry cohort of 877 German women, 97.7 % of the patients accounted for the institutional sample (N = 857) and 65.8 % accounted for the regional sample (N = 577). Stage distributions, relative survival ratios and indices of the German breast cancer network improved over time. Developed indices converged with SEER (2004). CONCLUSIONS: Effectiveness gap between one exemplary German breast cancer network and international benchmark defined by SEER has been closed. Reasons are manifold, and further research is recommended.
Authors: M Sant; R Capocaccia; A Verdecchia; J Estève; G Gatta; A Micheli; M P Coleman; F Berrino Journal: Int J Cancer Date: 1998-08-31 Impact factor: 7.396
Authors: Milena Sant; Claudia Allemani; Franco Berrino; Michel P Coleman; Tiiu Aareleid; Gilles Chaplain; Jan Willem Coebergh; Marc Colonna; Paolo Crosignani; Arlette Danzon; Massimo Federico; Lorenzo Gafà; Pascale Grosclaude; Guy Hédelin; Josette Macè-Lesech; Carmen Martinez Garcia; Henrik Møller; Eugenio Paci; Nicole Raverdy; Brigitte Tretarre; Evelyn M I Williams Journal: Cancer Date: 2004-02-15 Impact factor: 6.860
Authors: James S Michaelson; Melvin Silverstein; Dennis Sgroi; Justin A Cheongsiatmoy; Alphonse Taghian; Simon Powell; Kevin Hughes; Arthur Comegno; Kenneth K Tanabe; Barbara Smith Journal: Cancer Date: 2003-11-15 Impact factor: 6.860
Authors: Michel P Coleman; Manuela Quaresma; Franco Berrino; Jean-Michel Lutz; Roberta De Angelis; Riccardo Capocaccia; Paolo Baili; Bernard Rachet; Gemma Gatta; Timo Hakulinen; Andrea Micheli; Milena Sant; Hannah K Weir; J Mark Elwood; Hideaki Tsukuma; Sergio Koifman; Gulnar Azevedo E Silva; Silvia Francisci; Mariano Santaquilani; Arduino Verdecchia; Hans H Storm; John L Young Journal: Lancet Oncol Date: 2008-07-17 Impact factor: 41.316
Authors: Adam Gondos; Bernd Holleczek; Maryska Janssen-Heijnen; David H Brewster; Freddie Bray; Stefano Rosso; Timo Hakulinen; Hermann Brenner Journal: Int J Cancer Date: 2009-12-01 Impact factor: 7.396